BlackRock Health Sciences Term Trust
 
 
 
 
基本資料
種類: ETF
費用比率%: 1.37
資產淨值: 16.63
成立日期: 29/01/2020
 
分析
市值分佈:
49.01%
大市值
2.57%
中市值
0.84%
小市值
持股比例加總可能不達100%,原因包括ETF持有現金或衍生工具。
 
 
行業分佈 國家/地區分佈
 
投資組合
 (更新時間: 07/03/2026 05:58) 總持有投資項目: 77  
0%
 
100%
     10大 (21.47%)
代號 名稱 佔比% 持有日期
GKOSGlaukos Corp0.1331/12/2025
SRRKScholar Rock Holding Corp0.1331/12/2025
SGMTSagimet Biosciences0.1231/12/2025
RGNXREGENXBIO0.1131/12/2025
ARVNArvinas0.1131/12/2025
BNTXBioNTech SE American Depositary Share0.1031/12/2025
ASNDAscendis Pharma A/S0.0831/12/2025
ORICOric Pharmaceuticals0.0831/12/2025
NGNENeurogene0.0731/12/2025
AUTLAutolus Therapeutics plc0.0731/12/2025
VYGRVoyager Therapeutics0.0531/12/2025
BHVNBiohaven Ltd0.0531/12/2025
NYXHNyxoah SA0.0531/12/2025
ALLOAllogene Therapeutics0.0531/12/2025
TCRXTScan Therapeutics0.0431/12/2025
FDMT4D Molecular Therapeutics0.0331/12/2025
BCYCBicycle Therapeutics plc0.0231/12/2025
  1    2    3   4  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.